A carregar...
Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review
Immune checkpoint inhibitors (ICIs) belong to a new group of anticancer drugs targeting T-cell proteins involved in the activation of immune response toward malignancies. Their introduction into clinical practice was a milestone in modern cancer treatment. However, the significant advantage of ICIs...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bioscientifica
2020-10-01
|
| Colecção: | Endocrine Connections |
| Assuntos: | |
| Acesso em linha: | https://ec.bioscientifica.com/view/journals/ec/9/10/EC-20-0342.xml |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|